Streetbeat News

AYRWF

Ayr Wellness Inc.

Industry

Medicinal and Botanical Manufacturing

Open

0.18

Mkt cap

18M

Volume

90K

High

0.18

P/E Ratio

-0.05

52-wk high

3.46

Low

0.15

Div yield

N/A

52-wk low

0.15

Zuanic & Associates has analyzed the financial net debt metrics of 20 multi-state operators (MSOs) in the cannabis industry to identify potential candidates for equity raises or debt restructuring. Trulieve and Curaleaf have the highest net debt among the group. The report also includes income tax payables, gross leases, and warrant derivative liabilities in its definition of net debt, revealing that Curaleaf, Cresco, and Trulieve hold the highest absolute 'broad' net financial debt. Several MSOs, including Acreage, Ascend Wellness, AYR, Columbia Care, 4Front, iAnthus, Jushi, StateHouse, and TerrAscend, present a higher probability of needing equity raises.

Portfolio Pulse from Nicolás Jose Rodriguez

September 21, 2023 | 2:55 pm

Florida's cannabis market is showing robust growth with a valuation of over $1.4 billion and a volume growth rate surpassing 30%. The potential for recreational legalization has driven stock prices upward. Planet 13 (OTC:PLNHF) plans to acquire VidaCann, a significant player in the state. Independent operators like Cansortium and Green Dragon are rising, while multi-state operators like Surterra, iAnthus, and Columbia Care (OTC:CCHWF) might consider divesting their Florida assets. Trulieve (OTC:TCNNF) remains the market leader, but Verano (OTC:VRNOF) and AYR (OTC:AYRWF) are experiencing significant growth.

Portfolio Pulse from Nicolás Jose Rodriguez

September 15, 2023 | 2:30 pm

The U.S. cannabis sector has been under pressure with low volume and sentiment. However, the sector saw a significant development when the Department of Health and Human Services (HHS) recommended moving marijuana to a Schedule III designation, which would lower the effective tax rate for U.S. plant-touching companies from 70%+ to a normal rate. This could potentially lead to a 2-3x turn for U.S. cannabis plant-touching securities. The U.S. cannabis ETF (MSOS) has been under pressure, but the potential regulatory changes could have a positive impact.

Portfolio Pulse from Todd Harrison

September 10, 2023 | 9:58 pm

The Department of Health and Human Services' recommendation to reclassify marijuana as a Schedule III drug could significantly boost cash flows for cannabis companies. Following the news, MSOS ETF surged by 21%, while State House Holdings, Columbia Care, Jushi, and Ayr Wellness also saw substantial gains. The removal of Section 280E could reduce income tax rates for profitable cannabis companies and provide a significant cash flow benefit.

Portfolio Pulse from Nicolás Jose Rodriguez

August 31, 2023 | 8:34 pm

The Department of Health and Human Services (HHS) has recommended the reclassification of marijuana as a Schedule III drug, which has led to significant market reactions. MSOS ETF (NYSE:MSOS) surged 21%, State House Holdings Inc. (OTC:STHZF) rose by 74%, Columbia Care (OTC:CCHWF) increased by 38%, Jushi (OTC:JUSH) rose by 32%, and Ayr Wellness (OTC:AYRWF) increased by 29%. The reclassification could potentially alleviate certain regulatory burdens, particularly the IRS's 280E tax implications.

Portfolio Pulse from Nicolás Jose Rodriguez

August 31, 2023 | 5:45 pm

The cannabis industry is introducing new products that redefine consumption experiences. Entourage Health Corp has launched several new product lines, including the Dime Bag Pre-Roll Series and the Syndicate Cannabis Collection. Tilray Brands is entering the beverage market with two tropical ready-to-drink offerings by its premium wellness brand, Solei. LEVIA, in collaboration with Kynd, is introducing a Cherry Lemonade flavor seltzer, available at Ayr Wellness Inc's Massachusetts outlets. Organigram Holdings Inc. has unveiled Canada's first whole-flower-derived THCV products, 'SHRED' and 'Trailblazer'.

Portfolio Pulse from Joana Scopel

August 29, 2023 | 3:40 pm

The article lists the cannabis stocks that gained and lost on August 24, 2023. Notable gainers include EVIO, Red White & Bloom Brands, and CBD Unlimited. Major losers include Choom Holdings, Radient Technologies, and Target Group.

Portfolio Pulse from Benzinga Insights

August 24, 2023 | 9:30 pm

The article lists the marijuana stocks that gained and lost on August 22, 2023. The biggest gainers were Red White & Bloom Brands (OTC:RWBYF), Radient Technologies (OTC:RDDTF), and Heritage Cannabis Holding (OTC:HERTF). The biggest losers were EVIO (OTC:EVIO), Choom Holdings (OTC:CHOOF), and Tetra Bio Pharma (OTC:TBPMF).

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 9:30 pm

The cannabis sector experienced mixed performance on August 21, 2023, with several stocks seeing significant gains, while others suffered losses. Notable gainers include Radient Technologies (OTC:RDDTF), Trees (OTC:CANN), and 1933 Industries (OTC:TGIFF), while Red White & Bloom Brands (OTC:RWBYF), CBD Of Denver (OTC:CBDD), and Tetra Bio Pharma (OTC:TBPMF) were among the biggest losers.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 9:30 pm

Q2 2023 earnings releases for cannabis companies have shown that many beat their EBITDA estimates, but full-year projections tell a different story. Analysts had lowered EBITDA estimates, making it easier for companies to beat the consensus. However, six of the fourteen largest MSOs, including the five largest, have lower expected 2023 EBITDA than actual 2022 EBITDA. The group, in aggregate, is projected to be down 3.2% for 2023. Aggressive inventory management is likely to restrain the 2nd half EBITDA snapback. TerrAscend (OTC:TRSSF) and AYR’s (OTC:AYRWF) are mentioned as potential exceptions.

Portfolio Pulse from Viridian Capital Advisors

August 21, 2023 | 7:10 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.